Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-10,196
Closed -$487K 1694
2017
Q1
$461K Buy
+10,196
New +$433K ﹤0.01% 1522
2016
Q2
Sell
-10,969
Closed -$450K 2293
2016
Q1
$441K Buy
+10,969
New +$441K ﹤0.01% 1619
2015
Q2
Sell
-6,527
Closed -$331K 2620
2015
Q1
$323K Sell
6,527
-70,613
-92% -$3.38M ﹤0.01% 2006
2014
Q4
$3.52M Buy
+77,140
New +$3.74M 0.01% 719
2014
Q3
Sell
-9,068
Closed -$487K 2821
2014
Q2
$482K Sell
9,068
-23,544
-72% -$1.25M ﹤0.01% 2126
2014
Q1
$1.71M Buy
32,612
+12,079
+59% +$611K 0.01% 1266
2013
Q4
$1.1M Sell
20,533
-6,102
-23% -$315K ﹤0.01% 1767
2013
Q3
$1.35M Buy
26,635
+9,863
+59% +$502K ﹤0.01% 1741
2013
Q2
$864K Buy
+16,772
New +$894K ﹤0.01% 2070

Other funds holding SNY

Timber Hill's SNY Position: Q2 2017 in Review

Timber Hill sold out of Sanofi (SNY) in Q2 2017, closing a stake of 10,196 shares — an estimated $487K sold.

Timber Hill first reported a position in SNY in Q2 2013 and held it in 9 quarters. The position peaked at $3.52M in Q4 2014. 475 funds tracked by Wall St. Rank hold SNY as of Q2 2017.

  • Timber Hill reported no remaining Sanofi position as of Q2 2017 after selling out during the quarter.
  • Timber Hill sold 10,196 Sanofi shares in Q2 2017, an estimated $487K.
  • Timber Hill first reported a position in Sanofi in Q2 2013 and held it in 9 quarters.
  • Timber Hill's Sanofi position peaked at $3.52M in Q4 2014.
  • 475 funds tracked by Wall St. Rank held Sanofi as of Q2 2017.

Based on Timber Hill's 13F filing for Q2 2017, filed 9 Aug 2017.